Health

Researchers Develop Tool To Predict Breast Cancer Treatment Nerve Damage

In a significant breakthrough, researchers at Linkoping University in Sweden have developed a pioneering tool aimed at predicting the risk of nerve damage resulting from breast cancer treatment.

This innovative approach could revolutionize how doctors tailor treatments to minimize side effects for individual patients.

Breast cancer treatments, particularly those involving taxanes like docetaxel and paclitaxel, often lead to peripheral neuropathy, a debilitating condition affecting the nervous system.

While these treatments have significantly improved survival rates, many patients experience long-term side effects that can severely impact their quality of life.

Kristina Engvall, a researcher at Linkoping University, emphasized the prevalence and impact of nerve damage post-treatment.

Highlighting the profound implications for patient well-being, stating, “Nerve damage, particularly persistent numbness, and tingling in the feet, is distressingly common among patients treated with taxanes.”

Published in the journal npj Precision Oncology, the study surveyed 337 breast cancer patients treated with taxanes, tracking various side effects over a span of two to six years.

Results indicated that over a quarter of patients reported cramps, numbness, tingling, and difficulty in motor functions such as opening jars or climbing stairs.

To develop their predictive model, the researchers analyzed genetic data from the patients and employed advanced machine-learning techniques.

This enabled them to identify genetic markers associated with a heightened risk of developing persistent neuropathic symptoms.

“The models we developed successfully categorized patients into two groups: those at high risk of enduring side effects and those with a likelihood similar to the general population,” Kristina noted, highlighting the tool’s potential to personalize treatment strategies.

Also Read: Study Finds Higher Rates Of Anxiety & Depression In Women Post Cardiac Arrest

Mankrit Kaur

Recent Posts

Corporate India Reports 7.2% Sales Growth In FY25, RBI Data Shows

Corporate India saw a sales growth of 7.2% in FY25, up from 4.7% the previous…

7 mins ago

India Posts $13.5 Billion Current Account Surplus In Q4 FY25: RBI

India recorded a current account surplus of $13.5 billion or 1.3% of GDP in Q4…

18 mins ago

PM Modi Pays Tribute To Acharya Vidyanand Ji Maharaj On His Centenary Year

Prime Minister Narendra Modi launched the centenary celebrations of Acharya Vidyanand Ji Maharaj at Vigyan…

33 mins ago

Ram Temple In Ayodhya Draws Over 55 Million Devotees Since Consecration

Since the consecration of Lord Ram at the Ram Temple on January 22, 2024, Ayodhya…

35 mins ago

Over 70% Of Indian Startups Now Rely On AI For Core Business Functions: Meta Report

India’s startup ecosystem is witnessing a major shift, with over 70% of startups now integrating…

47 mins ago

India’s Economic Outlook Remains Positive Amid Global Headwinds: Finance Ministry

India’s economic outlook remains positive in the face of global turbulence, according to the Ministry…

49 mins ago